Ari Winasti Satyagraha

Senior Scientist


  • B.Sc honors in Genetics (University of Western Ontario, 1995)
  • Postgraduate Diploma in Molecular Biology (University of Queensland, 1998)
  • Doktor scientiarum humanarum in Biochemistry (University of Heidelberg, 2003)



  • Primaquine therapy, G6PD deficiency, Malaria, Hereditary Spherocytosis, SAO, protein purification, proteomics


  • DFAT G6PD Champion (2018)
  • APMEN Research Grant (2017)
  • Strategic Award under the Li Ka Shing Foundation Global Health Programme (University of Oxford, 2014)
  • PATH (G6PD diagnostic tests in Sumba, 2013)
  • APMEN (Asia Pacific Malaria Elimination Network) Research Grant (2011, 2013)
  • APMEN Travel Award 2013
  • University of Queensland Alumni Award (2012)
  • L’oreal Women in Science Award Nominee (2005)
  • Graduiertenkolleg (2000-2003)
  • Dean’s List at the University of Queensland (1997)


  1. Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities.
    Int Health. 2018 Sep 3. pii: 5090118. doi: 10.1093/inthealth/ihy060.
  2. Accurate light microscopic diagnosis of South-East Asian ovalocytosis.
    Int J Lab Hematol. 2018 Jul 13. doi: 10.1111/ijlh.12900.
  3. Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.
    Malar J. 2018 Jun 20;17(1):241. doi: 10.1186/s12936-018-2380-8.
  4. Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.
    Malar J. 2017 Apr 5;16(1):141. doi: 10.1186/s12936-017-1784-1.
  5. Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
    PLoS Negl Trop Dis. 2016 Feb 19;10(2):e0004457. doi: 10.1371/journal.pntd.0004457. eCollection 2016 Feb.
  6. G6PD Deficiency at Sumba in Eastern Indonesia Is Prevalent, Diverse and Severe: Implications for Primaquine Therapy against Relapsing Vivax Malaria.
    PLoS Negl Trop Dis. 2015 Mar 6;9(3):e0003602. doi: 10.1371/journal.pntd.0003602. eCollection 2015 Mar.
  7. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells.
    Transl Res. 2014 Sep 28. pii: S1931-5244(14)00336-3. doi: 10.1016/j.trsl.2014.09.009.
  8. Glucose-6-Phosphate Dehydrogenase Deficiency and Primaquine Hemolytic Toxicity
    Encyclopedia of Malaria. 2014. Springer. New York: 1-16
  9. Spatial distribution of G6PD deficiency variants across malaria-endemic regions.
    Malar J. 2013 Nov 15;12:418. doi: 10.1186/1475-2875-12-418.
  10. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.
    Malar J. 2013 Nov 4;12:391. doi: 10.1186/1475-2875-12-391.
  11. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.
    Malar J. 2013 Mar 27;12:112. doi: 10.1186/1475-2875-12-112.
  12. G6PD deficiency: global distribution, genetic variants and primaquine therapy.
    Adv Parasitol. 2013;81:133-201. doi: 10.1016/B978-0-12-407826-0.00004-7.
  13. Genetic continuity across a deeply divergent linguistic contact zone in North Maluku, Indonesia.
    BMC Genet. 2011 Nov 18;12:100. doi: 10.1186/1471-2156-12-100.